Carmen Sanges is a medical biotechnologist with a PhD in Molecular Biology and Medical Biotechnology and over seven years of industry experience in clinical operations and translational research. She is EU Initiatives Scientific & Strategic Project Lead at the Cellular Immunotherapy Program of the University Hospital Würzburg (UKW) and Executive Director of the T2EVOLVE Association. Carmen coordinates and contributes to multiple European initiatives in advanced therapies, with a strong focus on CAR-T and TCR cell therapies, regulatory science, manufacturing innovation, and patient access, and is committed to building sustainable, cross-stakeholder ecosystems across Europe.